Finance

Lists
Why is PLUR down 3.67%?
Dive Deeper
PLUR:NASDAQ
Pluri Inc
$1.05
-3.67%
(-0.040) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PLUR...
Open
$1.17
High
$1.17
Low
$1.04
Mkt. cap
12.96M
Avg. vol.
50.19K
Volume
14.76K
52-wk high
$4.29
52-wk low
$0.85
EPS
-$2.44
Beta
0.64
Shares outstanding
12.61M
No. of employees
103
Open
$1.17
High
$1.17
Low
$1.04
Mkt. cap
12.96M
Avg. vol.
50.19K
Volume
14.76K
52-wk high
$4.29
52-wk low
$0.85
EPS
-$2.44
Beta
0.64
Shares outstanding
12.61M
No. of employees
103
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
1 day ago
Pluri: Fiscal Q1 Earnings Snapshot
Profile
Pluri Inc., formerly Pluristem Therapeutics, is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment. According to the company's website, it extracts adult stem cells exclusively from postnatal placentas. Wikipedia
About Pluri Inc
CEOYaky Yanay
Employees103
FoundedMay 11, 2001
HeadquartersHaifa, Haifa District, Israel
SectorHealth Care
IndustryBiotechnology
Websitepluri-biotech.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
316.00K
198.00K
167.00K
335.00K
Cost of goods sold
201.00K
112.00K
111.00K
139.00K
Cost of revenue
201.00K
112.00K
111.00K
139.00K
Research and development expenses
3.93M
3.83M
3.96M
3.37M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.53M
2.77M
2.63M
2.37M
Operating expense
6.46M
6.59M
6.59M
5.74M
Total operating expenses
6.67M
6.70M
6.70M
5.88M
Operating income
-6.35M
-6.51M
-6.54M
-5.55M
Other non operating income
289.00K
53.00K
6.00K
-82.00K
EBT including unusual items
-6.14M
-6.88M
-6.18M
-6.19M
EBT excluding unusual items
-6.14M
-6.88M
-6.18M
-6.19M
Income tax expense
-8.00K
-8.00K
-8.00K
-1.00K
Effective tax rate
0.13%
0.12%
0.13%
0.02%
Other operating expenses
-
-
-
-
Net income
-5.85M
-6.54M
-5.55M
-5.88M
Net profit margin
-1,851.27%
-3,304.55%
-3,322.16%
-1,755.22%
Earnings per share
-0.65
-
-
-
Interest and investment income
193.00K
118.00K
104.00K
73.00K
Interest expense
-229.00K
-231.00K
-237.00K
-235.00K
Net interest expenses
-36.00K
-113.00K
-133.00K
-162.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-6.22M
-6.38M
-6.41M
-5.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps